DNLI relative valueRV
Denali Therapeutics Inc.. How this company compares with the rest of its GICS sub-industry on the figures it reported in its last annual filing.
DNLI's return on equity of -50.6% ranks in the 30th percentile of 24 Biotechnology sub-industry peers, fiscal periods ending between 2025-11-30 and 2025-12-31.
As of . Source: SEC EDGAR XBRL company facts. Method and limitations.
Against 24 Biotechnology peers
| Metric | DNLI | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 0 USD | 62.4M USD | 6th | 17 |
| Revenue YoY | n/a | n/a | n/a | 1 |
| Gross margin | n/a | n/a | n/a | 1 |
| Operating margin | n/a | -361.1% | n/a | 16 |
| Net margin | n/a | -296.2% | n/a | 16 |
| Return on equity | -50.6% | -29.7% | 30th | 24 |
| P / E | n/a | n/a | n/a | n/a |
| 1 year | n/a | n/a | n/a | n/a |
Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Fiscal periods ending between 2025-11-30 and 2025-12-31. Prices as of 2026-09-21. Every fundamental figure is one full fiscal year from one filing. Nothing is trailing twelve months and nothing is converted between currencies. P/E combines the market-price snapshot with annual earnings; one-year return uses market prices, dated separately above. 0001714899-26-000021
Peer set, 24 companies
VCYT, DYN, RCUS, VKTX, GRTX, LEGN, CLDX, QURE, MBX, GRAL, IDYA, ARQT, ZLAB, CPRX, ATAI, ELVN, IMNM, CELC, PHVS, PGEN, TNGX, NAMS, NRIX, IRON
Left out: ZLDPF (no annual filing).
What could not be compared
- 69 The filer did not report this line in the filing used.
- 24 The denominator is zero or negative, so the ratio has no meaning.
- 22 The price series does not reach back to the start of this window.
- 6 The newest price is more than 10 days old.
- 4 Fewer than 5 peers carry a comparable value, so no median, quartile or percentile is published.
- 2 This filer reports an ordinary share count and trades as a depositary receipt at a ratio Kresmion does not store, so price times shares would be wrong.
- 1 No annual filing (10-K, 20-F or 40-F) with fiscal-year figures.
Free account
Open the relative value desk with a free account
An account turns this page into a research desk: thirty-one metrics over the whole peer set instead of eight, the distribution behind each median, the metric's history against the peer band, an editable peer set, the filing behind every cell, and CSV. The table above stays free.
Cite this data
Every fundamental figure is the full fiscal year reported on one annual SEC filing (10-K, 20-F or 40-F), named by accession. Peers are the company's GICS sub-industry. A median, quartile or percentile is published only when at least five peers carry a comparable value, and a peer reporting in another currency is excluded from a level rather than converted. P/E combines the market-price snapshot with annual earnings; one-year return uses market prices, dated separately above.
Upstream: SEC EDGAR XBRL company facts
Kresmion, "DNLI relative value, Kresmion", data as of 2026-02-26, https://kresmion.com/tools/relative-value/DNLI. Upstream data: SEC EDGAR XBRL company facts.